✨ Medicines Approval
25 NOVEMBER NEW ZEALAND GAZETTE 4231
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Gonal-F.
Active Ingredient(s): Follitropin alpha 150 IU.
Dosage Form: Powder for injection.
NZ Sponsor: Douglas Pharmaceuticals Limited.
Manufacturer(s): Laboratoires Serono SA (Switzerland), Zone Industrielle de l’Ouriettaz, Aubonne, Switzerland.
Serono Pharma SpA, Zone Industriale di Modugno, Bari, Italy.
Product: Gonal-F.
Active Ingredient(s): Follitropin alpha 75 IU.
Dosage Form: Powder for injection.
NZ Sponsor: Douglas Pharmaceuticals Limited.
Manufacturer(s): Laboratoires Serono SA., Zone Industrielle de l’Ouriettaz, Aubonne, Switzerland.
Serono Pharma SpA, Zone Industriale di Modugno, Bari, Italy.
Product: Humalog.
Active Ingredient(s): Insulin lispro 100 U/mL.
Dosage Form: Solution for injection (vial).
NZ Sponsor: Eli Lilly and Company (NZ) Limited.
Manufacturer(s): Lilly France SA, Fegersheim, France.
Product: Humalog.
Active Ingredient(s): Insulin lispro 100 U/mL.
Dosage Form: Solution for injection (cartridge).
NZ Sponsor: Eli Lilly and Company (NZ) Limited.
Manufacturer(s): Lilly France SA, Fegersheim, France.
Product: Mabthera.
Active Ingredient(s): Rituximab 10 mg/mL.
Dosage Form: Concentrate for infusion.
NZ Sponsor: Roche Products (New Zealand) Limited.
Manufacturer(s): Genentech Inc, South San Francisco, California, United States of America.
IDEC Pharmaceuticals Corp., San Diego, California, United States of America.
Product: NovoSeven.
Active Ingredient(s): Factor VIIa (recombinant human) 1.2 mg.
Dosage Form: Powder for injection.
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited.
Manufacturer(s): Novo Nordisk A/S, Gentofte, Denmark.
Product: NovoSeven.
Active Ingredient(s): Factor VIIa (recombinant human) 2.4 mg.
Dosage Form: Powder for injection.
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited.
Manufacturer(s): Novo Nordisk A/S, Gentofte, Denmark.
Product: NovoSeven.
Active Ingredient(s): Factor VIIa (recombinant human) 4.8 mg.
Dosage Form: Powder for injection.
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited.
Manufacturer(s): Novo Nordisk A/S, Gentofte, Denmark.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 177
NZLII —
NZ Gazette 1999, No 177
✨ LLM interpretation of page content
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981
- Minister of Health